Editorial: Effective pain management in hematological malignancies

Expert Review of Hematology

Volumn 2, Issue 3, 2009, Pages 219-222

  Niscola, Pasquale ^a  

^a S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CORTICOSTEROID; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ANALGESIA; BONE PAIN; CONTINUOUS INFUSION; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; MUCOSA INFLAMMATION; PAIN; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; SORE THROAT; BLOOD DISEASE; PAIN ASSESSMENT;

ANALGESICS; HEMATOLOGIC NEOPLASMS; HUMANS; PAIN; PAIN MEASUREMENT;

EID: 77953433395     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.09.20     Document Type: Editorial

References (25)

1. Niscola P, Arcuri E, Giovannini M et al. Pain syndromes in haematological malignancies: An overview. Hematol. J. 5(4), 293-303 (2004).
2. Bauduer F, Capdupuy C, Renoux M. Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support. Care Cancer 8(4), 302-306 (2000).
3. Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk. Res. 27(6), 481-488 (2003).
4. Niscola P, Cartoni C, Romani C et al. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: An Italian survey. Ann. Hematol. 86(9), 671-676 (2007).
5. Niscola P, Romani C, Cartoni C et al. Epidemiology of pain in hospital haematological setting: An Italian survey. Leuk. Res. 32(1), 197-198 (2008).
6. Niscola P, Perrotti AP, del Poeta G et al. Case reports: Zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes 14(2), 45-47 (2007).
7. Coutaux A, Salomon L, Rosenheim M et al.; Pain Committee, Hôpital de la Pitié- Salpêtrière, AP-HP, Paris, France. Care related pain in hospitalized patients: A cross-sectional study. Eur. J. Pain 12(1), 3-8 (2008).
8. Lidén Y, Landgren O, Arnér S, Sjölund KF, Johansson E. Procedure-related pain among adult patients with hematologic malignancies. Acta Anaesthesiol. Scand. 53(3), 354-363 (2009).
9. Niscola P, Romani C, Scaramucci L et al. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant. 41(9), 757-764 (2008).
10. Tariman JD, Love G, McCullagh E, Sandifer S; IMF Nurse Leadership Board. Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clin. J. Oncol. Nurs. 12(3 Suppl.), 29-36 (2008).
11. Niscola P, Romani C, Cupelli L et al. Mucositis in patients with hematologic malignancies: An overview. Haematologica 92(2), 222-231 (2007).
12. Bruera E, Schoeller T, Wenk R et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J. Pain Symptom Manage. 10(5), 348-355 (1995).
13. Mercadante S, Radbruch L, Caraceni A et al.; Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: Consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94(3), 832-839 (2002).
14. Gordon-Williams RM, Dickenson AH. Central neuronal mechanisms in cancerinduced bone pain. Curr. Opin. Support. Palliat. Care (1), 6-10 (2007).
15. Gosselin RD, Dansereau MA, Pohl M et al. Chemokine network in the nervous system: A new target for pain relief. Curr. Med. Chem. 15(27), 2866-2875 (2008).
16. Davis MP, Walsh D. Cancer pain: How to measure the fifth vital sign. Cleve. Clin. J. Med. 71(8), 625-632 (2004).
17. Caraceni A, Cherny N, Fainsinger R et al. Pain measurement tools and methods in clinical research in palliative care: Recommendations of an Expert Working Group of the European Association of Palliative Care. J. Pain Symptom Manage. 23(3), 239-255 (2002). (Pubitemid 34219075)
18. Roodman GD. Skeletal imaging and management of bone disease. Hematology Am. Soc. Hematol. Educ. Program 2008, 313-319 (2008).
19. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: A systematic review. J. Clin. Oncol. 25(11), 1423-1436 (2007).
20. McGeeney BE. Adjuvant agents in cancer pain. Clin. J. Pain 24(Suppl. 10), S14-S20 (2008).
21. Hanks GW, Conno F, Cherny N et al.; Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: The EAPC recommendations. Br. J. Cancer 84(5), 587-593 (2001).
22. Niscola P, Scaramucci L, Romani C et al. Opioids in pain management of bloodrelated malignancies. Ann. Hematol. 85(8), 489-501 (2006).
23. World Health Organization. Cancer Pain Relief. WHO, Geneva, Switzerland (1986).
24. Pergolizzi J, Böger RH, Budd K et al. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8(4), 287-313 (2008).
25. Cherny N, Ripamonti C, Pereira J et al.; Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: An evidence-based report. J. Clin. Oncol. 19(9), 2542-2554 (2001).